FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/12/078764 [Registered on: 30/12/2024] Trial Registered Prospectively
Last Modified On: 30/12/2024
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   Wound Healing Activity of a Traditional Vranaropak Formulation 
Scientific Title of Study   Preclinical and Clinical Study to Evaluate the Vranaropana Karma (Wound Healing Activity) of Sarala (Pinus roxburghii Sargent) Exudate 
Trial Acronym  NILL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Amit Kumar Taraphdar 
Designation  Professor Department of Dravyaguna IPGAER at SVSP Hospital 
Affiliation  Institute of Post Graduate Ayurvedic Education and Research at SVSP Hospital 
Address  Dept. of Dravyaguna, Room no T2, IPGAER at SVSP Hospital, 294/3/1 A.P.C Road, Kolkata
294/3/1 A.P.C Road, Kolkata-700009
Kolkata
WEST BENGAL
700009
India 
Phone  9874849650  
Fax    
Email  atipgaer@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Amit Kumar Taraphdar 
Designation  Professor Department of Dravyaguna IPGAER at SVSP Hospital 
Affiliation  Institute of Post Graduate Ayurvedic Education and Research at SVSP Hospital 
Address  Dept. of Dravyaguna, Room no T2, IPGAER at SVSP Hospital, 294/3/1 A.P.C Road, Kolkata
294/3/1 A.P.C Road, Kolkata-700009
Kolkata
WEST BENGAL
700009
India 
Phone  9874849650  
Fax    
Email  atipgaer@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Beauty Maity 
Designation  MD Scholar Dept of Dravyaguna IPGAER at SVSP Hospital 
Affiliation  Institute of Post Graduate Ayurvedic Education and Research at SVSP Hospital 
Address  Dept of Dravyaguna, Room no T2, IPGAER at SVSP Hospital, 294/3/1 A.P.C Road, Kolkata
294/3/1 A.P.C Road, Kolkata-700009
Kolkata
WEST BENGAL
700009
India 
Phone  7890184704  
Fax    
Email  beautymaity592@gmail.com  
 
Source of Monetary or Material Support  
Apothecary Dept. of Institute of Post Graduate Ayurvedic Education and Research at SVSP Hospital, 294/3/1 A.P.C Road, Kolkata-700009, West Bengal, India  
 
Primary Sponsor  
Name  Institute of Post Graduate Ayurvedic Education and Research at SVSP Hospital 
Address  294/3/1 A.P.C Road, Kolkata-700009, West Bengal, India 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Amit Kumar Taraphdar  Institute of Post Graduate Ayurvedic Education and Research at SVSP Hospital  Room No. T2, Dept. of Dravyaguna, 294/3/1 A.P.C Road, Kolkata- 700009
Kolkata
WEST BENGAL 
9874849650

atipgaer@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethical Committee for Clinical Trial on Human Subjects, IPGAER, Kolkata  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:T149||Unspecified injury. Ayurveda Condition: VRANAH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmDrugClassical(1) Medicine Name: Sarala (Pinus roxburghii) exydate, Reference: Bhavaprakasa Nighantu, Route: Topical, Dosage Form: Malahara/ Ointment/ Balm, Dose: 00(NA), Frequency: bd, Bhaishajya Kal: Sabhakta, Duration: 28 Days, anupAna/sahapAna: No, Additional Information: Dose of test drug- Quantity sufficient for local application, twice daily for 28days
2Comparator Arm (Non Ayurveda)-DrugMupirocin 2% w/w ointment, Topical Antibiotic, Dose- Quantity sufficient for local appliction twice daily for 28days
 
Inclusion Criteria  
Age From  20.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  The clinical study will be single blind clinical study, with two groups of patients (male and female both) suffering from acute wound, partial fistulectomy wound in the OPD and IPD of the hospital at IPGAER, Kolkata  
 
ExclusionCriteria 
Details  1. Age below 20years or above 60years
2. Pre-existing diabetes mallitus
3. History of severe trauma
4. Pregnancy and lactating mother
5. Excessive P/R bleeding
6. Sexually transmitted disease
7. Malignancy
8. Patient with H/O multiple surgical intervention  
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Case Record Numbers 
Blinding/Masking   Participant Blinded 
Primary Outcome  
Outcome  TimePoints 
The safety and clinical efficacy of the test drug by monitoring the wound area, wound appearance, TC, DC, ESR, Hb%   28 days 
 
Secondary Outcome  
Outcome  TimePoints 
Safe, Effective, Economical wound healing ayurvedic drug for the suffering patients  28 days 
 
Target Sample Size   Total Sample Size="20"
Sample Size from India="20" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2/ Phase 3 
Date of First Enrollment (India)   20/01/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="8"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   This clinical study, which will take place at the OPD of the IPGAER at SVSP Hospital, is a randomized, parallel-grouped control trial of a test drug comparing the safety and efficacy of Mupirocin for 28days in 20 patients suffering from different type of wounds. The primary outcome of this research is to evaluate the therapeutic efficacy of the test drug for its potential wound healing activity. The secondary outcome is to determine the safety of the test drug on quality of life among the patients suffering from different dermal injury. 
Close